Csaba Szabo Selected Research

Smoke Inhalation Injury

8/2011	Burn and smoke injury activates poly(ADP-ribose)polymerase in circulating leukocytes.
2/2011	Beneficial pulmonary effects of a metalloporphyrinic peroxynitrite decomposition catalyst in burn and smoke inhalation injury.
3/2010	Molecular biological effects of selective neuronal nitric oxide synthase inhibition in ovine lung injury.
1/2010	Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock.
11/2009	Beneficial effect of a hydrogen sulphide donor (sodium sulphide) in an ovine model of burn- and smoke-induced acute lung injury.
1/2009	Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury.
8/2008	gamma-Tocopherol nebulization by a lipid aerosolization device improves pulmonary function in sheep with burn and smoke inhalation injury.
4/2008	Neuronal nitric oxide synthase inhibition attenuates cardiopulmonary dysfunctions after combined burn and smoke inhalation injury in sheep.
7/2003	Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Csaba Szabo Research Topics

Disease

34	Neoplasms (Cancer) 04/2024 - 09/2005
32	Inflammation (Inflammations) 09/2022 - 05/2002
23	Burns 01/2019 - 07/2003
19	Sepsis (Septicemia) 01/2022 - 09/2002
16	Colonic Neoplasms (Colon Cancer) 10/2022 - 07/2013
16	Reperfusion Injury 10/2018 - 02/2002
13	Acute Lung Injury 11/2022 - 08/2003
13	Ischemia 01/2021 - 08/2003
11	Septic Shock (Toxic Shock Syndrome) 01/2022 - 04/2003
11	Critical Illness (Critically Ill) 01/2020 - 04/2003
10	Necrosis 11/2022 - 05/2008
9	Lung Injury 09/2017 - 12/2002
9	Smoke Inhalation Injury 08/2011 - 07/2003
8	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 03/2012
8	Infarction (Infarctions) 12/2017 - 02/2002
8	Myocardial Ischemia (Ischemic Heart Diseases) 07/2014 - 02/2002
6	Down Syndrome (Down's Syndrome) 04/2024 - 01/2020
6	Atherosclerosis 01/2022 - 07/2008
6	Infections 01/2021 - 09/2002
5	Hypoxia (Hypoxemia) 11/2020 - 04/2008
5	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 04/2014
5	Diabetes Mellitus 01/2017 - 05/2002
5	Shock 03/2013 - 09/2002
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2012 - 09/2002
4	Hyperglycemia 12/2017 - 08/2011
4	Myocardial Infarction 12/2017 - 02/2002
4	Endotoxemia 02/2017 - 11/2006
4	Pulmonary Edema 02/2011 - 04/2008
4	Stroke (Strokes) 11/2009 - 12/2006
3	Breast Neoplasms (Breast Cancer) 04/2024 - 03/2023
3	Multiple Organ Failure (MODS) 12/2021 - 05/2009
3	Hypercholesterolemia 10/2018 - 12/2017
3	Hemorrhage 10/2018 - 06/2008
3	Wounds and Injuries (Trauma) 10/2018 - 02/2016
3	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 12/2013
3	Edema (Dropsy) 10/2011 - 12/2002
2	Neuroinflammatory Diseases 01/2023 - 12/2021
2	Brain Injuries (Brain Injury) 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

42	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 04/2024 - 09/2007
41	EnzymesIBA 04/2024 - 04/2003
29	CystathionineIBA 04/2024 - 08/2011
17	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2022 - 04/2003
15	LyasesIBA 10/2023 - 08/2011
15	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022 - 04/2003
14	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2005
13	3-mercaptopyruvate sulphurtransferaseIBA 03/2023 - 02/2015
12	SmokeIBA 10/2018 - 07/2003
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 05/2002
10	Peroxidase (Myeloperoxidase)IBA 01/2020 - 06/2004
10	salicylhydroxamic acid (SHAM)IBA 10/2018 - 04/2008
9	Oxygen (Dioxygen)IBA 11/2020 - 11/2006
8	Adenosine Triphosphate (ATP)IBA 04/2024 - 11/2006
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2002
8	NitrogenIBA 01/2019 - 07/2008
8	Poly Adenosine Diphosphate RiboseIBA 01/2015 - 02/2002
7	Aminooxyacetic AcidIBA 04/2024 - 07/2013
7	Ligases (Synthetase)IBA 01/2021 - 02/2002
7	Oxidants (Oxidizing Agents)IBA 01/2016 - 05/2002
6	olaparibIBA 01/2022 - 01/2017
6	Mitochondrial DNA (mtDNA)IBA 01/2021 - 10/2010
6	CytokinesIBA 11/2016 - 01/2005
6	Peroxynitrous Acid (Peroxynitrite)IBA 02/2011 - 07/2003
6	INO 1001IBA 05/2010 - 08/2003
5	Sulfides (Thioethers)IBA 01/2022 - 05/2008
5	3-nitrotyrosineIBA 01/2022 - 08/2003
5	GasotransmittersIBA 01/2021 - 03/2013
5	CreatinineIBA 01/2019 - 01/2016
5	LipopolysaccharidesIBA 02/2017 - 04/2003
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 08/2011
5	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 06/2008 - 02/2002
4	Interleukin-6 (Interleukin 6)IBA 09/2022 - 05/2012
4	HMGB1 Protein (HMG1)IBA 01/2021 - 09/2009
4	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 01/2020 - 01/2016
4	Malondialdehyde (Propanedial)IBA 01/2020 - 01/2015
4	Urea (Carbamide)FDA LinkGeneric 01/2019 - 01/2016
4	Reactive Nitrogen SpeciesIBA 02/2011 - 07/2003
3	NF-kappa B (NF-kB)IBA 11/2022 - 05/2002
3	Interleukin-10 (Interleukin 10)IBA 09/2022 - 09/2008
3	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022 - 03/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2013
3	ProdrugsIBA 01/2021 - 08/2012
3	Messenger RNA (mRNA)IBA 01/2021 - 10/2010
3	Phosphotransferases (Kinase)IBA 02/2020 - 10/2011
3	Amylases FDA Link 01/2020 - 11/2016
3	GYY 4137IBA 10/2018 - 05/2015
3	Nitric Oxide Synthase (NO Synthase)IBA 10/2017 - 05/2009
3	Free RadicalsIBA 11/2015 - 05/2002
3	ChemokinesIBA 05/2015 - 04/2008
3	AntioxidantsIBA 02/2015 - 04/2003
3	Evans Blue (Blue, Evans)FDA Link 05/2010 - 05/2008
3	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2010 - 04/2008
3	EndotoxinsIBA 10/2003 - 12/2002
2	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2019

Therapy/Procedure

22	Therapeutics 08/2022 - 03/2005
10	Investigational Therapies (Experimental Therapy) 11/2022 - 05/2002
8	Ligation 01/2019 - 08/2003
5	Punctures 01/2019 - 03/2013
4	Resuscitation 01/2022 - 03/2009
4	Critical Care (Surgical Intensive Care) 10/2018 - 03/2009
4	Anesthesia 04/2012 - 01/2009